Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia
The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Abstract
Abnormal expression of the N-methyl-D-Aspartate (NMDA) receptor and its interacting molecules of the postsynaptic density (PSD) are thought to be involved in the pathophysiology of schizophrenia. Frontal regions of neocortex including dorsolateral prefrontal (DLPFC) and anterior cingulate cortex (ACC) are essential for cognitive and behavioral functions that are affected in schizophrenia. In this study, we have measured protein expression of two alternatively spliced isoforms of the NR1 subunit (NR1C2 and NR1C2') as well as expression of the NR2A-D subunits of the NMDA receptor in DLPFC and ACC in post-mortem samples from elderly schizophrenic patients and a comparison group. We found significantly increased expression of NR1C2' but not of NR1C2 in ACC, suggesting altered NMDA receptor cell membrane expression in this cortical area. We did not find significant changes in the expression of either of the NR1 isoforms in DLPFC. We did not detect changes of any of the NR2 subunits studied in either cortical area. In addition, we studied expression of the NMDA-interacting PSD molecules NF-L, SAP102, PSD-95 and PSD-93 in ACC and DLPFC at both transcriptional and translational levels. We found significant changes in the expression of NF-L in DLPFC, and PSD-95 and PSD-93 in ACC; increased transcript expression was associated with decreased protein expression, suggesting abnormal translation and/or accelerated protein degradation of these molecules in schizophrenia. Our findings suggest abnormal regional processing of the NMDA receptor and its associated PSD molecules, possibly involving transcription, translation, trafficking and protein stability in cortical areas in schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, PSD-95 protein levels are reduced in the schizophrenia cortex59.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [59]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
MacDonald, A. W., Cohen, J. D., Stenger, V. A., & Carter, C. S. (2000) · Science · doi:10.1126/science.288.5472.1835 · Cited by 3,666
Anterior Cingulate Conflict Monitoring and Adjustments in Control
Kerns, J. G., Cohen, J. D., MacDonald, A. W., Cho, R. Y., Stenger, V. A., & Carter, C. S. (2004) · Science · doi:10.1126/science.1089910 · Cited by 2,891
Domain Interaction Between NMDA Receptor Subunits and the Postsynaptic Density Protein PSD-95
Kornau, H.-C., Schenker, L. T., Kennedy, M. B., & Seeburg, P. H. (1995) · Science · doi:10.1126/science.7569905 · Cited by 1,904
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
Goff, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 915
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Niethammer, M., Kim, E., & Sheng, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02157.1996 · Cited by 750
Kinesin Superfamily Motor Protein KIF17 and mLin-10 in NMDA Receptor-Containing Vesicle Transport
Setou, M., Nakagawa, T., Seog, D.-H., & Hirokawa, N. (2000) · Science · doi:10.1126/science.288.5472.1796 · Cited by 708
Cited by
Items 101–200 of 222
Yoo, T., Kim, S.-G., Yang, S. H., Kim, H., Kim, E., & Kim, S. Y. (2020) · Molecular Autism · doi:10.1186/s13229-020-00324-7 · Cited by 40
Cannabidiol modulation of hippocampal glutamate in early psychosis
O’Neill, A., Annibale, L., Blest‐Hopley, G., Wilson, R. P., Giampietro, V., & Bhattacharyya, S. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211001107 · Cited by 38
GLT‐1 upregulation impairs prepulse inhibition of the startle reflex in adult rats
Bellesi, M., Melone, M., Gubbini, A., Battistacci, S., & Conti, F. (2009) · Glia · doi:10.1002/glia.20798 · Cited by 36
Miller, C. L., & Dulay, J. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.03.015 · Cited by 37
Haybaeck, J., Weis, S., Postruznik, M., Miller, C. L., Llenos, I. C., & Dulay, J. R. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s72536 · Cited by 34
Forsyth, J. K., Bachman, P., Mathalon, D. H., Roach, B. J., Ye, E. M., & Asarnow, R. F. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw193 · Cited by 35
PSD-93 Attenuates Amyloid-β-Mediated Cognitive Dysfunction by Promoting the Catabolism of Amyloid-β
Yu, L., Liu, Y., Yang, H., Zhu, X., Cao, X., Gao, J., Zhao, H., & Xu, Y. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170320 · Cited by 34
Receptor‐associated proteins and synaptic plasticity
Bruneau, E., Esteban, J. A., & Akaaboune, M. (2008) · The FASEB Journal · doi:10.1096/fj.08-107946 · Cited by 39
Ju, P., & Cui, D. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv135 · Cited by 34
Grüter, T., Wiescholleck, V., Dubovyk, V., Aliane, V., & Manahan‐Vaughan, D. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00117 · Cited by 35
Sun, P., Wang, J., Gu, W., Cheng, W., Jin, G.-Z., Friedman, E., Zheng, J., & Zhen, X. (2009) · Cell Research · doi:10.1038/cr.2009.30 · Cited by 35
Candemir, E., Kollert, L., Weißflog, L., Geis, M., Müller, A., Post, A. M., O’Leary, A., Harro, J., Reif, A., & Freudenberg, F. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.01.008 · Cited by 38
Ago, Y., Condro, M. C., Tan, Y., Ghiani, C. A., Colwell, C. S., Cushman, J. D., Fanselow, M. S., Hashimoto, H., & Waschek, J. A. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3848-z · Cited by 32
BERNSTEIN, H., Sahin, J., Smalla, K., Gundelfinger, E. D., Bogerts, B., & KREUTZ, M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.05.038 · Cited by 28
PSD-95 regulates CRFR1 localization, trafficking and β-arrestin2 recruitment
Dunn, H. A., Chahal, H. S., Caetano, F. A., Holmes, K. D., Yuan, G. Y., Parikh, R., Heit, B., & Ferguson, S. S. G. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.013 · Cited by 27
AMPA receptor subunit localization in schizophrenia anterior cingulate cortex
Benesh, J. L., Mueller, T., & Meador‐Woodruff, J. H. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.01.025 · Cited by 29
Self-citationAbad-Perez, P., Payá, F. J. M., Martínez-Otero, L., Borrell, V., Redondo, R. L., & Brotons‐Mas, J. R. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.03.022 · Cited by 27
Regional differences in expression of β-tubulin isoforms in schizophrenia
Moehle, M. S., Ludueña, R. F., Haroutunian, V. H., Meador‐Woodruff, J. H., & McCullumsmith, R. E. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2011.12.010 · Cited by 28
Self-citationStamboulian, S., Legendre, A., Chabrol, T., Platel, J., Pernot, F., Duveau, V., Roucard, C., Baudry, M., & Depaulis, A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.009 · Cited by 26
Modeling combined schizophrenia-related behavioral and metabolic phenotypes in rodents
Sarnyai, Z., Jashar, C., & Olivier, B. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.016 · Cited by 29
Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia
Bilecki, W., & Maćkowiak, M. (2023) · Genes · doi:10.3390/genes14020243 · Cited by 27
Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia
Kimoto, S., Glausier, J. R., Fish, K. N., Volk, D. W., Bazmi, H. H., Arion, D., Datta, D., & Lewis, D. A. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv139 · Cited by 23
Genetic analysis of nitric oxide synthase 1 variants in schizophrenia and bipolar disorder
Silberberg, G., Ben‐Shachar, D., & Navon, R. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31112 · Cited by 25
de Bartolomeis, A., Vellucci, L., Simone, G. D., Mazza, B., Barone, A., & Ciccarelli, M. (2023) · Cells · doi:10.3390/cells12040574 · Cited by 23
Lee, L.-C., Cho, Y.-C., Lin, P., Ting-Chi, Y., Chang, C.-Y., & Yeh, T.-K. (2015) · Neural Plasticity · doi:10.1155/2016/6851592 · Cited by 25
Epigenetic reprogramming of cortical neurons through alteration of dopaminergic circuits
Brami‐Cherrier, K., Anzalone, A., Ramos, M., Forné, I., Macciardi, F. M., Imhof, A., & Borrelli, E. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.67 · Cited by 23
zhang, T., Tang, Y., Yang, X., Wang, X., Ding, S., Huang, K., Liu, Y., & Lang, B. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102520 · Cited by 25
de Bartolomeis, A., Iasevoli, F., Tomasetti, C., & Buonaguro, E. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8962-8 · Cited by 21
Piva, A., Caffino, L., Mottarlini, F., Pintori, N., Castillo Díaz, F., Fumagalli, F., & Chiamulera, C. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02352-7 · Cited by 21
Zetzsche, D. A., Preuss, U. W., Frodl, T., Watz, D., Schmitt, G., Koutsouleris, N., BORN, C., Reiser, M. F., MOLLER, H., & Meisenzahl, E. M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.07.027 · Cited by 25
Chen, Q., Li, X., Lu, J.-S., Liu, Y., Lee, J.-H. A., Chen, Y., Shi, W., Fan, K., & Zhuo, M. (2021) · Molecular Brain · doi:10.1186/s13041-021-00744-3 · Cited by 20
A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia
Kim, Y., Choi, J., & Park, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040734 · Cited by 21
Horner, A. E., McLaughlin, C. L., Afinowi, N. O., Bussey, T. J., Saksida, L. M., Komiyama, N. H., Grant, S. G. N., & Kopanitsa, M. V. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13792 · Cited by 21
de Bartolomeis, A., Avagliano, C., Vellucci, L., D’Ambrosio, L., Manchia, M., D’Urso, G., Buonaguro, E. F., & Iasevoli, F. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.019 · Cited by 19
High cervical spinal schwannoma; microneurosurgical management: an experience of 15 cases.
Chowdhury, F. H., Haque, M. R., & Sarker, M. H. (2013) · PubMed · Cited by 22
Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development
Stanton‐Turcotte, D., Hsu, K., Moore, S. A., Yamada, M., Fawcett, J. P., & Iulianella, A. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0124-22.2022 · Cited by 20
Gupta, P., Uner, O. E., Nayak, S., Grant, G. R., & Kalb, R. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200477 · Cited by 21
Mutant disrupted‐in‐schizophrenia 1 in astrocytes: Focus on glutamate metabolism
Abazyan, S., Yang, E. J., Abazyan, B. N., Xia, M., Yang, C., Rojas, C. J., Slusher, B. S., Sattler, R., & Pletnikov, M. V. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23459 · Cited by 19
McGuier, N. S., Padula, A. E., Mulholland, P. J., & Chandler, L. J. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00028 · Cited by 17
Neurexophilin 1 suppresses the proliferation of hematopoietic progenitor cells
Kinzfogl, J., Hangoc, G., & Broxmeyer, H. E. (2011) · Blood · doi:10.1182/blood-2010-12-325381 · Cited by 19
Dendritic spine morphology and dynamics in health and disease
Webb, D. J., Lee, S. N., & Zhang, H. (2015) · Cell Health and Cytoskeleton · doi:10.2147/chc.s82214 · Cited by 20
A role for endothelial NMDA receptors in the pathophysiology of schizophrenia
Intson, K., Geissah, S., McCullumsmith, R. E., & Ramsey, A. J. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.10.004 · Cited by 16
Hernández‐Frausto, M., López‐Rubalcava, C., & Galván, E. J. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.01.036 · Cited by 15
Elmers, J., Colzato, L. S., Akgün, K., Ziemssen, T., & Beste, C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102037 · Cited by 16
Molteni, R., PASINI, M., Moraschi, S., Gennarelli, M., Drago, F., Racagni, G., & Riva, M. A. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.02.007 · Cited by 15
The 5-HT1A Receptor: A Signaling Hub Linked to Emotional Balance
Chattopadhyay, A. (2007) · CRC Press eBooks · doi:10.1201/9781420005752-12 · Cited by 15
Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function
Benneyworth, M. A., Basu, A. C., & Coyle, J. T. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2023-4 · Cited by 16
Adraoui, F. W., Douw, L., Martens, G. J. M., & Maas, D. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097680 · Cited by 31
Llewellyn‐Smith, I. J., & Mueller, P. J. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.02.024 · Cited by 15
Jacob, M., Roach, B. J., Hamilton, H., Carrión, R. E., Belger, A., Duncan, E., Johannesen, J., Keshavan, M. S., Loo, S. K., Niznikiewicz, M. A., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.01.028 · Cited by 13
Giordano, G. M., Pezzella, P., Giuliani, L., Fazio, L., Mucci, A., Perrottelli, A., Blasi, G., Amore, M., Rocca, P., Rossi, A., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13010083 · Cited by 14
p140Cap Regulates the Composition and Localization of the NMDAR Complex in Synaptic Lipid Rafts
Angelini, C., Morellato, A., Alfieri, A., Pavinato, L., Cravero, T., Bianciotto, O. T., Salemme, V., Natalini, D., Centonze, G., Raspanti, A., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1775-21.2022 · Cited by 13
Fanous, A. H., Middleton, F. A., Gentile, K. L., AMDUR, R. L., Maher, B. S., Zhao, Z., Sun, J., Medeiros, H., Carvalho, C. B., Ferreira, S. R., et al. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32041 · Cited by 14
Evidence of Glutamatergic Dysfunction in the Pathophysiology of Schizophrenia
Hammond, J. C., Shan, D., Meador‐Woodruff, J. H., & McCullumsmith, R. E. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1056-4_15 · Cited by 17
Self-citationMatosin, N., Green, M. J., Andrews, J. L., Newell, K. A., & Fernandez, F. (2015) · Neuroreport · doi:10.1097/wnr.0000000000000491 · Cited by 13
The 5-HT 1A Receptor: A Signaling Hub Linked to Emotional Balance
Banerjee, P., Kanjilal, B., & Mehta, M. (2007) · Frontiers in neuroscience · doi:10.1201/9781420005752.ch7 · Cited by 14
Neonatal phencyclidine as a model of sex-biased schizophrenia symptomatology in adolescent mice
Dutra-Tavares, A. C., de Souza, T. P., Silva, J. D. O., Semeão, K. A., Mello, F. F., Filgueiras, C. C., Ribeiro‐Carvalho, A., Manhães, A. C., & Abreu‐Villaça, Y. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06434-3 · Cited by 14
Kovacs, K. M., Lajtha, Á., & Sershen, H. W. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.02.008 · Cited by 11
Proteomic analysis of normal murine brain parts.
Taraslia, V., Kouskoukis, A., Anagnostopoulos, A. K., Stravopodis, D. J., Margaritis, L. H., & Tsangaris, G. T. (2013) · PubMed · Cited by 10
Kędracka–Krok, S., Świderska, B., Jankowska, U., Skupień-Rabian, B., Solich, J., & Dziedzicka‐Wasylewska, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.028 · Cited by 10
Holter, K. M., Lekander, A., Pierce, B. E., Sands, L. P., & Gould, R. W. (2024) · Pharmaceuticals · doi:10.3390/ph17020237 · Cited by 9
Poulia, N., Delis, F., Brakatselos, C., Ntoulas, G., Asprogerakas, M.-Z., & Antoniou, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.746935 · Cited by 10
Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse
Kerner, B. (2009) · The Open Psychiatry Journal · doi:10.2174/1874354400903010001 · Cited by 10
A decrease in protein level and a missense polymorphism of KIF17 are associated with schizophrenia
Ratta‐apha, W., Mouri, K., Boku, S., Ishiguro, H., Okazaki, S., Otsuka, I., Sora, I., Arinami, T., Shirakawa, O., & Hishimoto, A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.09.031 · Cited by 9
PSD-95 Protein: A Promising Therapeutic Target in Chronic Pain
Ma, L., Sun, D., Wen, S., Yuan, J., Li, J., Tan, X., & Cao, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04485-x · Cited by 8
Lee, D., Seo, J., Jeong, H. C., Lee, H., & Lee, S. B. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.756613 · Cited by 10
17β-estradiol status alters NMDAR function and antipsychotic-like activity in female rats
Holter, K. M., Klausner, M. G., Hite, M. H., Moriarty, C., Barth, S. H., Pierce, B. E., Iannucci, A. N., Sheffler, D. J., Cosford, N. D. P., Bimonte‐Nelson, H. A., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02996-0 · Cited by 7
Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia
Vinnakota, C., Hudson, M. R., Jones, N. C., Sundram, S., & Hill, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411835 · Cited by 7
Cheng, M.-C., Lu, C.-L., Luu, S.-U., Tsai, H.-M., Hsu, S.-H., Chen, T., & Chen, C. (2010) · PLoS ONE · doi:10.1371/annotation/8e156c1b-2369-45da-93f7-99701f5935d2 · Cited by 7
Intragenic L1 Insertion: One Possibility of Brain Disorder
Son, J.-H., Do, H., & Han, J. (2022) · Life · doi:10.3390/life12091425 · Cited by 6
The Role of Astrocytes in the Pathophysiology of Schizophrenia.
Steffek, A. E. (2007) · Deep Blue (University of Michigan) · Cited by 6
Бокша, И. С., Терешкина, Е. Б., Savushkina, O. K., Prokhorova, T. A., Vorobyeva, E. A., & Burbaeva, G. S. (2018) · Neurochemical Journal · doi:10.1134/s1819712418010026 · Cited by 6
Lu, C., Chang, H., Hsu, L., Lee, M., Cheng, J., Wu, D., & Lin, W. (2023) · Pharmaceuticals · doi:10.3390/ph16020280 · Cited by 5
Alterations of Neurotransmitter Receptors in Schizophrenia: Evidence from Postmortem Studies
Kristiansen, L. V., Cowell, R. M., Biscaia, M., McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_14 · Cited by 6
Self-citationLőrincz, A., Ashaber, M., & Nusser, Z. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.0645-25.2025 · Cited by 4
Bauer, D., McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-74351-6_6 · Cited by 7
Self-citationBanerjee, A., Borgmann‐Winter, K. E., Ray, R., & Hahn, C.-G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00016-1 · Cited by 3
Mallien, A. S., Pfeiffer, N., Vogt, M. A., Chourbaji, S., Sprengel, R., Gass, P., & Inta, D. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.750106 · Cited by 3
What value do NMDA receptor antagonist models of schizophrenia have for novel drug discovery?
Adell, A. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2562017 · Cited by 2
Glutamatergic Synaptic Dysregulation in Schizophrenia
Coyle, J. T., Basu, A. C., & Benneyworth, M. A. (2012) · Wiley eBooks · doi:10.1002/9781118309421.ch5 · Cited by 2
Association study on the DLG4 gene and schizophrenia in the Chinese Han population
Li, X., Liu, B., Wang, Y., Zhao, Q., Shen, Q., Yu, T., Chen, S., Yang, F., Li, W., Gao, L., et al. (2013) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283643671 · Cited by 2
Ünal, G., & Arıcıoğlu, F. (2018) · MARMARA PHARMACEUTCAL JOURNAL · doi:10.12991/mpj.2018.57 · Cited by 2
Chen, M., Wang, W., Song, W., Qian, W., & Lin, G. N. (2021) · Life · doi:10.3390/life11020172 · Cited by 2
Role of the different domains of PSD-95 in basal synaptic transmission
Bonnet, A. D. S. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-509 · Cited by 2
Buttermore, E. D., Anderson, N. C., Chen, P.-F., Makhortova, N. R., Kim, K. H., Wafa, S. M. A., Dwyer, S., Micozzi, J. M., Winden, K. D., Zhang, B., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.924956 · Cited by 1
Impact of cannabinoids on synapse markers in an SH-SY5Y cell culture model
Jahn, K., Blumer, N., Wieltsch, C., Duzzi, L., Fuchs, H. R., Meister, R., Groh, A., Westhoff, M. S., Krüger, T. H. C., Bleich, S., et al. (2024) · Schizophrenia · doi:10.1038/s41537-024-00498-6 · Cited by 2
Differential DNA-methylation of synaptic genes in CSF and blood in schizophrenia
Jahn, K., Groh, A., Riemer, O., Sun, S., Moschny, N., Bleich, S., Frieling, H., Konen, F. F., & Skripuletz, T. (2026) · Schizophrenia · doi:10.1038/s41537-026-00738-x · Cited by 1
GluN2D NMDA Receptors: Bridging Physiology and Pathology
Narasimhan, K. K. S., & Dravid, S. M. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.02.012 · Cited by 2
Vrajová, M., Bubeníková‐Valešová, V., & Klaschka, J. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-s1-s147 · Cited by 1
PSD-95 Interacts with Dopamine D1-Receptor: Functional Implication
Li, L., Sun, P., & Zhen, X. (2011) · American Journal of Biomedical Sciences · doi:10.5099/aj110400313 · Cited by 1
Structural Alterations of Synapses in Psychiatric and Neurodegenerative Disorders
Penzes, P., Remmers, C. L., Cahill, M. E., Jones, K. A., VanLeeuwen, J., & Woolfrey, K. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00009-2 · Cited by 1
Synaptic Abnormalities and Neuroplasticity
Gao, R., Russell, T. A., & Penzes, P. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00022-5 · Cited by 2
The Convergence of Glutamate and GABA Dysregulation in Schizophrenia
Monaco, S. A., Coley, A. A., & Gao, W. (2016) · InTech eBooks · doi:10.5772/65870 · Cited by 1
Glutamate, Glutamatergic Drugs and Schizophrenia
Muguruza, C., & Callado, L. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_17 · Cited by 1
Lutgen, V. (2012) · e-Publications@Marquette (Marquette University) · Cited by 2
Funk, A. J., Labilloy, G., Reigle, J. K., Alnafisah, R. S., Heaven, M. R., Roberts, R. C., Shamsaei, B., Greis, K. D., Meller, J., & McCullumsmith, R. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.04.076844 · Cited by 1
Soltani, A. (2014) · theses.fr (ABES) · doi:10.70675/26a65a76zeeb4z4c2fz8664z90cf5fd31f88 · Cited by 1
The biology of schizophrenia as a neurodevelopmental disorder
van Berlekom, A. B. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1269 · Cited by 1
Impact of open channel blockers on the surface dynamics and organization of NMDA receptors
Fernandes, A. (2020) · theses.fr (ABES) · doi:10.70675/d12c14b2z7a80z4668z9c48z8e2c0e41c009 · Cited by 2
Rocco, B. R. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
Metadata
- Authors
- Kristiansen, L. V., Beneyto, M., Haroutunian, V, & Meador-Woodruff, J. H.
- Affiliations
- University of Alabama at Birmingham (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Kristiansen, L V
- Venue
- Molecular Psychiatry
- Published
- 2006-05-16
- Volume
- 11
- Issue
- 8
- Pages
- 737-747
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1969409914
- Cited by
- 220
- References
- 84
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 9 · 2022: 6 · 2021: 11 · 2020: 12 · 2019: 6 · 2018: 10 · 2017: 11 · 2016: 13 · 2015: 20 · 2014: 11 · 2013: 14 · 2012: 13
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01mh045212-05)
- National Institute of Mental Health (MH 53327, R01MH053327, MH 45212, R01MH064673, MH-064673)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- schizophrenia, NMDA receptor, NR2 subunits, postsynaptic density, dorsolateral prefrontal cortex, anterior cingulate cortex, PSD-95, PSD-93, SAP102, neurofilament light chain, alternative splicing, post-transcriptional regulation, protein stability, receptor trafficking
- MeSH terms
- Disks Large Homolog 4 Protein, Aged, Aged, 80 and over, Female, Gyrus Cinguli, Humans, Male, Membrane Proteins, Middle Aged, Nerve Tissue Proteins, Nuclear Proteins, Schizophrenia, Transcription Factors, Blotting, Western, Gene Expression, Receptors, N-Methyl-D-Aspartate, Neurofilament Proteins, Prefrontal Cortex, In Situ Hybridization, Tumor Suppressor Proteins, Intracellular Signaling Peptides and Proteins, Guanylate Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.